We speculate that hyperactivation of NRF2 in LUAD may lead to over-expression of LAMC1 that ultimately enhances the tumor cell invasion, migration, and metastasis and inhibition of NRF2 pathway is a promising approach for the lung cancer therapy [35, 58]. Here, LAMC1 is linked to lung carcinoma.